Benjamin Reardon and Emmanuel J Favaloro/LinkedIn
Feb 5, 2026, 16:20
Emmanuel J Favaloro: New Study on Biomarkers for Coagulation Disorders
Emmanuel J Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Biomolecules (MDPI):
“Latest publication from the Sydney Centres for Thrombosis and Haemostasis. Again ably led by Ben Reardon. Biomarkers of Coagulation Disorders.”
Title: Biomarkers of Coagulation Disorders—Where to from Here?
Authors: Benjamin Reardon, Leonardo Pasalic, Emmanuel J. Favaloro
Read the Full Article on Biomolecules (MDPI)
Find more posts featuring Emmanuel J Favaloro on Hemostasis Today.
-
Mar 21, 2026, 17:22Sean Lybrand: Supporting Children with ALL with ACT 4 Children in Armenia
-
Mar 21, 2026, 17:14Shira Roth: Candidate Biomarkers to Predict Post-Surgical VTE in Mesothelioma
-
Mar 21, 2026, 17:09Peter Antevy: Revealing How SWiFT Is Highlighting Prehospital System Limitations
-
Mar 21, 2026, 17:07Wolfgang Miesbach: Clinical Evidence for Newly Approved Fibrinogen Concentrate in Congenital Fibrinogen Deficiency
-
Mar 21, 2026, 17:07Archil Jaliashvili: NATO Blood Panel Warns That The System Won’t Hold Under Real Surge Conditions
-
Mar 21, 2026, 16:59Athanasios Frydas: Is It Safe to Skip TEE Before Rhythm Control in Low Thromboembolic Risk Patients?
-
Mar 21, 2026, 16:56Kalyan Roy: LTOWB as a Practical Approach to Rapid Transfusion in Major Bleeding
-
Mar 21, 2026, 16:47Francisco Chacón-Lozsán: Insights on Intermediate High Risk Pulmonary Embolism from ACVC 2026
-
Mar 21, 2026, 16:38Tarik Elagha: Should You Have Lp(a) Checked?